Assessment
casirivimab/imdevimab
Treatment of COVID-19 in adults and adolescents aged 12 years and older weighing at least 40 kg, who do not require supplemental oxygen therapy and who are at increased risk of severe COVID-19
- Modules
- IQWiG assessments · G-BA decisions
- Connections
- 2
Connected evidence
2 relations